Carboplatin
OncoPharm
00:00
Creatinine assay changes and GFR capping controversy
John explains IDMS assay effects lowering creatinine, the FDA's GFR cap at 125, and resulting dosing concerns.
Play episode from 07:45
Transcript
John explains IDMS assay effects lowering creatinine, the FDA's GFR cap at 125, and resulting dosing concerns.
